These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


354 related items for PubMed ID: 15791292

  • 1. Effect of BM 17.0744, a PPARalpha ligand, on the metabolism of perfused hearts from control and diabetic mice.
    Aasum E, Cooper M, Severson DL, Larsen TS.
    Can J Physiol Pharmacol; 2005 Feb; 83(2):183-90. PubMed ID: 15791292
    [Abstract] [Full Text] [Related]

  • 2. Treatment of type 2 diabetic db/db mice with a novel PPARgamma agonist improves cardiac metabolism but not contractile function.
    Carley AN, Semeniuk LM, Shimoni Y, Aasum E, Larsen TS, Berger JP, Severson DL.
    Am J Physiol Endocrinol Metab; 2004 Mar; 286(3):E449-55. PubMed ID: 14600074
    [Abstract] [Full Text] [Related]

  • 3. Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism.
    Gilde AJ, van der Lee KA, Willemsen PH, Chinetti G, van der Leij FR, van der Vusse GJ, Staels B, van Bilsen M.
    Circ Res; 2003 Mar 21; 92(5):518-24. PubMed ID: 12600885
    [Abstract] [Full Text] [Related]

  • 4. Western diet impairs metabolic remodelling and contractile efficiency in cardiac hypertrophy.
    Akki A, Seymour AM.
    Cardiovasc Res; 2009 Feb 15; 81(3):610-7. PubMed ID: 19028723
    [Abstract] [Full Text] [Related]

  • 5. Fenofibrate modulates cardiac and hepatic metabolism and increases ischemic tolerance in diet-induced obese mice.
    Aasum E, Khalid AM, Gudbrandsen OA, How OJ, Berge RK, Larsen TS.
    J Mol Cell Cardiol; 2008 Jan 15; 44(1):201-9. PubMed ID: 17931655
    [Abstract] [Full Text] [Related]

  • 6. Metabolic effects of insulin on cardiomyocytes from control and diabetic db/db mouse hearts.
    Carroll R, Carley AN, Dyck JR, Severson DL.
    Am J Physiol Endocrinol Metab; 2005 May 15; 288(5):E900-6. PubMed ID: 15632103
    [Abstract] [Full Text] [Related]

  • 7. Glucose and insulin improve cardiac efficiency and postischemic functional recovery in perfused hearts from type 2 diabetic (db/db) mice.
    Hafstad AD, Khalid AM, How OJ, Larsen TS, Aasum E.
    Am J Physiol Endocrinol Metab; 2007 May 15; 292(5):E1288-94. PubMed ID: 17213470
    [Abstract] [Full Text] [Related]

  • 8. Metabolic gene switching in the murine female heart parallels enhanced mitochondrial respiratory function in response to oxidative stress.
    Essop MF, Chan WY, Taegtmeyer H.
    FEBS J; 2007 Oct 15; 274(20):5278-84. PubMed ID: 17892491
    [Abstract] [Full Text] [Related]

  • 9. Decreased contractile and metabolic reserve in peroxisome proliferator-activated receptor-alpha-null hearts can be rescued by increasing glucose transport and utilization.
    Luptak I, Balschi JA, Xing Y, Leone TC, Kelly DP, Tian R.
    Circulation; 2005 Oct 11; 112(15):2339-46. PubMed ID: 16203912
    [Abstract] [Full Text] [Related]

  • 10. Angiotensin II downregulates the fatty acid oxidation pathway in adult rat cardiomyocytes via release of tumour necrosis factor-alpha.
    Pellieux C, Montessuit C, Papageorgiou I, Lerch R.
    Cardiovasc Res; 2009 May 01; 82(2):341-50. PubMed ID: 19131364
    [Abstract] [Full Text] [Related]

  • 11. Chylomicron and palmitate metabolism by perfused hearts from diabetic mice.
    Neitzel AS, Carley AN, Severson DL.
    Am J Physiol Endocrinol Metab; 2003 Feb 01; 284(2):E357-65. PubMed ID: 12397026
    [Abstract] [Full Text] [Related]

  • 12. Salacia oblonga root improves cardiac lipid metabolism in Zucker diabetic fatty rats: modulation of cardiac PPAR-alpha-mediated transcription of fatty acid metabolic genes.
    Huang TH, Yang Q, Harada M, Uberai J, Radford J, Li GQ, Yamahara J, Roufogalis BD, Li Y.
    Toxicol Appl Pharmacol; 2006 Jan 01; 210(1-2):78-85. PubMed ID: 16129467
    [Abstract] [Full Text] [Related]

  • 13. Peroxisome proliferator activated receptor alpha/gamma dual agonist tesaglitazar attenuates diabetic nephropathy in db/db mice.
    Cha DR, Zhang X, Zhang Y, Wu J, Su D, Han JY, Fang X, Yu B, Breyer MD, Guan Y.
    Diabetes; 2007 Aug 01; 56(8):2036-45. PubMed ID: 17536062
    [Abstract] [Full Text] [Related]

  • 14. The effects of chronic trimetazidine treatment on mechanical function and fatty acid oxidation in diabetic rat hearts.
    Onay-Besikci A, Guner S, Arioglu E, Ozakca I, Ozcelikay AT, Altan VM.
    Can J Physiol Pharmacol; 2007 May 01; 85(5):527-35. PubMed ID: 17632588
    [Abstract] [Full Text] [Related]

  • 15. Cardiac peroxisome proliferator-activated receptor-alpha activation causes increased fatty acid oxidation, reducing efficiency and post-ischaemic functional loss.
    Hafstad AD, Khalid AM, Hagve M, Lund T, Larsen TS, Severson DL, Clarke K, Berge RK, Aasum E.
    Cardiovasc Res; 2009 Aug 01; 83(3):519-26. PubMed ID: 19398469
    [Abstract] [Full Text] [Related]

  • 16. Overexpression of angiotensinogen in the myocardium induces downregulation of the fatty acid oxidation pathway.
    Pellieux C, Aasum E, Larsen TS, Montessuit C, Papageorgiou I, Pedrazzini T, Lerch R.
    J Mol Cell Cardiol; 2006 Sep 01; 41(3):459-66. PubMed ID: 16859699
    [Abstract] [Full Text] [Related]

  • 17. Cardiac metabolism in mice: tracer method developments and in vivo application revealing profound metabolic inflexibility in diabetes.
    Oakes ND, Thalén P, Aasum E, Edgley A, Larsen T, Furler SM, Ljung B, Severson D.
    Am J Physiol Endocrinol Metab; 2006 May 01; 290(5):E870-81. PubMed ID: 16352676
    [Abstract] [Full Text] [Related]

  • 18. L-carnitine improvement of cardiac function is associated with a stimulation in glucose but not fatty acid metabolism in carnitine-deficient hearts.
    Broderick TL, Panagakis G, DiDomenico D, Gamble J, Lopaschuk GD, Shug AL, Paulson DJ.
    Cardiovasc Res; 1995 Nov 01; 30(5):815-20. PubMed ID: 8595631
    [Abstract] [Full Text] [Related]

  • 19. Pomegranate flower improves cardiac lipid metabolism in a diabetic rat model: role of lowering circulating lipids.
    Huang TH, Peng G, Kota BP, Li GQ, Yamahara J, Roufogalis BD, Li Y.
    Br J Pharmacol; 2005 Jul 01; 145(6):767-74. PubMed ID: 15880139
    [Abstract] [Full Text] [Related]

  • 20. Loss of stearoyl-CoA desaturase 1 inhibits fatty acid oxidation and increases glucose utilization in the heart.
    Dobrzyn P, Sampath H, Dobrzyn A, Miyazaki M, Ntambi JM.
    Am J Physiol Endocrinol Metab; 2008 Feb 01; 294(2):E357-64. PubMed ID: 18042664
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.